Skip to main content
Premium Trial:

Request an Annual Quote

John Linnan, May Van, Bruce Holm, James Glover

Premium

John Linnan has been appointed vice president of sales at Beverly, Mass.-based Agencourt Bioscience. Linnan comes to Agencourt from Applied Biosystems, where he most recently worked as district sales manager for New England. Prior to holding this position, Linnan was the regional sales manager for New England, mid-Atlantic, and Eastern Canada for Perspective Biosystems of Hertford, UK. He has also worked at Abbott Diagnostics in various sales positions. He holds a BA in marketing and management from James Madison University.

Agilent Technologies has named May Van as vice president and general manager of the consumables and services business in its Life Sciences and Chemical Analysis group, which includes Agilent’s proteomics business. Van, who joined Hewlett-Packard in 1997, and remained with Agilent when it spun out from its parent in 1999, is being promoted from a position as controller of the consumables and services business. Prior to joining the company, Van was the director of finance and administration at Integrated Circuit Systems. She has earned a bachelor’s degree of business administration in accounting from Texas Tech University, and an MBA from West Chester University in Pennsylvania.

Bruce Holm has been appointed director of the Buffalo Center of Excellence in Bioinformatics and Life Sciences of the University at Buffalo, which recently added a proteomics program. Holm was previously senior vice provost at the university, which is a branch of the State University of New York.

James Glover has been named chief financial officer of Beckman Coulter. Glover has held the post of interim CFO at Beckman Coulter since August 2003. He is a 21-year veteran of the company, having joined in 1983, and has most recently served as vice president, controller, and chief accounting officer, since early 2003. Glover, a certified public accountant, holds a BS in accounting from California State Polytechnic University, Pomona, as well as an MBA from Pepperdine University.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.